Trade Bayer ^BAYGn

MYQORZO® Approved for Adults with Symptomatic Obstructive HC

Bayer sues J&J over prostate cancer drug ad campaign - Ad Age

What Johnson & Johnson (JNJ)'s Prostate Cancer Drug Lawsuit Means For Shareholders

Assessing Bayer (XTRA:BAYN) Valuation After Mixed Annual Results And Strong Recent Share Returns

Bayer prostate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients

Bayer prostrate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients

Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - Stock Observer

Health Matters: Ontario family health teams struggle with lack of competitive funding | Watch News Videos Online

Mr. Brent Willis reports VOYAGEUR PHARMACEUTICALS ANNOUNCES

Bayer sues Johnson & Johnson over marketing of prostate cancer drug

Bayer Alleges J&J's Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA | Morningstar

(via TheNewswire) Calgary, Alberta, Canada - TheNewswire -

BAYN: Roundup Settlement Progress Will Unlock Future Equity Upside

Bayer identifies SOS1 inhibitors for cancer | BioWorld

Health Matters: Conservatives plan motion to review health benefits for asylum seekers | Watch News Videos Online

Trump Invokes Defense Act For Monsanto Chemicals: Bayer, Agribusiness ETFs In Focus On New Critical Mineral Status For Phosphorus

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Receives Average Rating of "Buy" from Brokerages - Markets Daily

Cancer vaccine shows promise in helping Lynch Syndrome patients in clinical trial results | Watch News Videos Online

Factbox-Top cases on the US Supreme Court's docket - Yahoo News Canada

Health Matters: Public plans shouldn't cover Alzheimer's medication, Canada's Drug Agency says | Watch News Videos Online

Trump issues order declaring glyphosate national defense priority - Yahoo News Canada

Bayer Remains Leader in Crop Sciences and Shows Burgeoning Innovation in Pharmaceuticals | Morningstar

Monsanto Trump declares chemical warfare on America, invokes national defense to expand production of cancer-linked GLYPHOSATE - NaturalNews.com

Zydus launches biosimilar for chronic retinal diseases - The Hindu

Trump Signs Order Protecting Glyphosate, Phosphorus Production

Bayer launches national campaign to curb counterfeit seed

Trump Issues Order To Support Production Of Glyphosate

Transforming Pharma: India's GCCs Emerge as Innovation Leaders in the Industry, ETPharma

Bayer: glyphosate shortages not expected outside the US after executive order

Explainer-Will Bayer's proposed $7.25 billion Roundup deal bring legal closure?

Trump Becomes the Glyphosate President: Declares Deadly Weed Killer a National Defense Resource - NaturalNews.com

Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusion

Bayer proposes $7.2 billion settlement to resolve Roundup weedkiller cases - CBS Chicago

Bayer Falls 8.4% On $7.25 Billion Plan

Bayer proposes plan to pay over $7B to settle Roundup cancer lawsuits | Fox Business

Dow Jones Top Company Headlines at 7 AM ET: Glencore's Earnings Fall Despite Second-Half Recovery | Bayer ... | Morningstar

Business NewsLine, Feb. 18, 2026 | Business | avpress.com

Bayer Shares Reverse Gains After Plan to Settle Roundup Litigation | Morningstar

Bayer retreats as investors sour on deal to settle Roundup litigation

Bayer shares make this surprising move after $7.25 billion Roundup settlement accord | Morningstar

Bayer Leverkusen interested in signing Leon Goretzka on a free transfer in the summer - Yahoo Sports

Bayer proposes $9.16 billion plan to settle Roundup cancer cases

Bayer stock gains on Roundup settlement

Bayer Proposes $7.25 Billion Class Settlement Over Roundup Cancer Lawsuits, ETPharma

Maria On Media: A Conversation With Bayer's Maria Givens 02/17/2026

Other news to note for Feb. 18, 2026 | BioWorld

Health Matters: Bayer offers multi-billion dollar settlement in Roundup lawsuits | Watch News Videos Online

Bayer Unveils $7.25 Billion Roundup Settlement Plan Amid Cancer Lawsuits, ETPharma

Bayer offers $10b to settle Roundup cancer US lawsuits

Bayer proposes $7.25 billion plan to settle Roundup cancer cases

Bayer Aktiengesellschaft Stock Rises 6% After Announcing Roundup Class Settlement Agreement

Bayer proposes $7.25B Roundup cancer claims settlement - Brownfield Ag News

Bayer proposes $7.2 billion settlement to resolve Roundup weedkiller cases - CBS Sacramento

Bayer seeks to pay more than $7 billion for Roundup settlements

Agrochemical giant Bayer's subsidiary Monsanto proposes class settlement for weedkiller cancer claims

Bayer proposes $10.25 billion plan for all Roundup cancer cases

Bayer Soars After $10.5 Billion Settlement On Current And Future Roundup Cancer Lawsuits | ZeroHedge

Bayer CEO says Roundup settlement is important addition to Supreme Court case

Bayer Expects Provisions to Increase to Nearly $14 Billion as It Aims to Settle All Roundup Cases | Morningstar

Bayer to make $10.5 billion push to settle roundup cases, Bloomberg reports

Response to: 'Comment on: 'Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results"

Bayer (0P6S) Receives a Hold from UBS | Markets Insider

Orion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Developments

Bayer Stroke Drug Success Raises New Questions For Valuation Gap

Bayer Stroke Trial Success Puts Asundexian And Valuation In Focus

Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer

Commitment to Innovation and Precision Breeding - Brownfield Ag News

Pesticide labeling language in House farm bill faces challenges

Zuellig Pharma acquires brands from Bayer to strengthen consumer healthcare portfolio

OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmology

Zuellig Pharma Acquires Bayer Consumer Brands

BAYN: Litigation Overhang Resolution Will Unlock Future Equity Upside

10 years on, NALCO yet to start gallium extraction project

How Investors Are Reacting To Corteva (CTVA) Spinning Off Seeds After Bayer Deal And Record Cash Flow

Kepler Capital Keeps Their Buy Rating on Bayer (0P6S) | Markets Insider

UBS Remains a Hold on Bayer (0P6S) | Markets Insider

EPA approves over-the-top use of dicamba for two years

The U.S. EPA Announces New Registration for Low-Volatility Dicamba Herbicides | Morningstar

EPA finalizes limited two-season use of OTT dicamba on cotton and soybeans with stricter safeguards

Bayer's asundexian cuts stroke risk 26% in phase III win | BioWorld

Corteva Resets With Bayer Deal And Seed Spin Off Plans

Bayer's Asundexian Shows 26% Stroke Recurrence Reduction in Late-Stage Trial, ETPharma

Bayer Stroke Trial Success Puts Asundexian And Valuation In Investor Focus

Experimental blood thinner cuts risk of stroke recurrence by 26%: Bayer | Health News - Business Standard

Bayer's Experimental Drug Reduces Stroke Risk by 26% in Study

Corteva Inc (CTVA) Q4 2025 Earnings Call Highlights: Record Free Cash Flow and Strategic ...

Bayer Touts Lynkuet, Its 'Blockbuster' Drug For Hot Flashes 02/05/2026

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Why the retail media boom is doomed if measurement isn't fixed | The Drum

Bayer Vietnam opens new healthcare warehouse in Tay Ninh

HSG forms entities in China, SG to hold newly acquired Avelox antibiotics business

Does Bayer (XTRA:BAYN) Offer Value After Its 107% One Year Share Price Surge?

Bayer Stroke Data And Vanderbilt Pact Shape Cardiovascular Pipeline Outlook

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update - Daily Political

Flight rules for clinical AI: lessons from aviation for human-AI collaboration in medicine

PSG, Bayer Leverkusen Negotiate Transfer for Young Player - Yahoo Sports

3 Vanguard ETFs to watch in 2026: VTV ETF, MGV ETF, VOO ETF

NVIDIA (NVDA) Stock Price & Overview 2026: What is Nvidia stock prediction?

Bitcoin slips under $63K: Will BTC price keep going down in 2026?

Novo Nordisk (NVO) stock analysis: Novo shares drop 16%, what’s next for NVO?

Commodity market today: gold (XAU/USD) and sliver dropped, what’s next?

Crude oil forecast today: Are WTI and Brent expected to rise in 2026?

Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?

Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?

Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?

Gold price forecast: XAU/USD remains under $5000, what’s next?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift